Skip to Content

93 T13 (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 60 mg / 120 mg)

Pill with imprint 93 T13 is Tan & White, Capsule-shape and has been identified as Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 60 mg / 120 mg. It is supplied by Teva Pharmaceuticals USA.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 60 mg / 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 T13

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release

Imprint:
93 T13
Strength:
60 mg / 120 mg
Color:
Tan & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide